Provider of in-vitro diagnostic tests for the detection of diseases. The company develops a portfolio of biomarker detection technologies with a focus on nucleic acid amplification that enables the accelerated prediction, diagnosis, and management of human and agricultural diseases. The company was founded in 2016 and headquartered in Missoula, United States. It has raised $8M in series a funding, with backing from America’s Seed Fund, HHS, Two Bear Capital, MonTEC. The company operates in the Life Sciences - Genomics, Life Sciences - Hematology space. Its offerings span Hematology - In Vitro Diagnostics Tests - Diversified and Genomics - Genomics Research - Biomarker Discovery.
← All startups
FYR Diagnostics
Series AProvider of in-vitro diagnostic tests for the detection of diseases. The company develops a portfolio of biomarker detection technologies with a focus on nucleic acid amplification that enables the accelerated prediction, diagnosis, and management of human and agricultural diseases. The company was founded in 2016 and headquartered in Missoula, United States. It has raised $8M in series a funding, with backing from…
About
Business model
Hematology > In Vitro Diagnostics Tests > Diversified,
Genomics > Genomics Research > Biomarker Discovery
Institutional investors
America’s Seed FundHHSTwo Bear CapitalMonTEC
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.